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Brca1 Controls Homology-Directed DNA Repair
BRCA1 and BRCA2, colocalize with RAD51 to nuclearMary Ellen Moynahan,*† Joanne W. Chiu,†
Beverly H. Koller,‡ and Maria Jasin†§ foci following DNA damage in mitotic cells and at form-
ing synaptonemal complexes in meiotic cells (Scully et*Department of Medicine
†Cell Biology Program al., 1997; Chen et al., 1998a). Although clearly a direct
interaction for BRCA2 (Mizuta et al., 1997; Sharan etMemorial Sloan-Kettering Cancer Center and
Cornell University Graduate School al., 1997; Wong et al., 1997; Chen et al., 1998b), the
association of BRCA1 with RAD51 is likely to be indirect,of Medical Sciences
New York, New York 10021 perhaps mediated by BRCA2 (Chen et al., 1998a).
BRCA1 has also been found associated with another‡Department of Medicine
University of North Carolina at Chapel Hill repair protein RAD50, colocalizing with it upon IR dam-
age in nuclear foci that are distinct from RAD51 fociChapel Hill, North Carolina 27599
(Zhong et al., 1999). Brca1-deficient (Gowen et al., 1998;
Shen et al., 1998; Abbott et al., 1999) and Brca2-deficient
(Connor et al., 1997; Sharan et al., 1997; Chen et al.,Summary
1998b; Patel et al., 1998) murine and human cells are
sensitive to DNA-damaging agents, including IR, furtherGermline mutations in BRCA1 confer a high risk of
breast and ovarian tumors. The role of BRCA1 in tumor implicating these proteins in DSB repair.
In mammals, as in other organisms, homologous re-suppression is not yet understood, but both transcrip-
tion and repair functions have been ascribed. Evidence combination can maintain genomic integrity through the
precise repair of a chromosomal DSB using the sisterthat BRCA1 is involved in DNA repair stems from its
association with RAD51, a homolog of the yeast pro- chromatid as the repair template (Johnson et al., 1999).
However, homologous repair of chromosomal DSBs us-tein involved in the repair of DNA double-strand breaks
(DSBs) by homologous recombination. We report here ing other homologous templates such as alleles or re-
peated sequences is potentially deleterious since it canthat Brca1-deficient mouse embryonic stem cells have
impaired repair of chromosomal DSBs by homologous result in loss of heterozygosity (LOH) or chromosomal
translocations, respectively (Moynahan and Jasin, 1997;recombination. The relative frequencies of homolo-
gous and nonhomologous DNA integration and DSB Richardson et al., 1998). Thus, loss of genes that regu-
late or participate in DSB repair processes can disturbrepair were also altered. The results demonstrate a
caretaker role for BRCA1 in preserving genomic integ- the balance of various repair pathways that have evolved
in mammalian cells to guard the genome from perturba-rity by promoting homologous recombination and lim-
iting mutagenic nonhomologous repair processes. tion. In this study, we sought to determine if Brca1 muta-
tion affects homologous recombination or nonhomolo-
gous repair events.Introduction
Chromosomal double-strand breaks (DSBs) can arise Results
from cellular DNA metabolism and from exogenous
DNA-damaging agents such as ionizing radiation (IR). Brca12/2 Cells Exhibit Gene Targeting Defects
Although IR causes an array of genotoxic damage, in- and Increased Nonhomologous Integration
cluding rapidly repaired single-strand breaks and oxida- The Brca1-deficient murine embryonic stem (ES) cell
tive damage, cellular lethality results from unrepaired or line 236.44 is hypersensitive to IR and hydrogen perox-
misrepaired DSBs (Ward, 1995). In mammalian cells, ide (but not UV) and has normal growth characteristics
two major pathways exist to repair chromosomal DSBs, and normal levels of p53 (Gowen et al., 1998; L. C. Gowen
homologous recombination and nonhomologous end and B. H. K., unpublished data). We have taken two
joining (NHEJ) (Liang et al., 1998). The first IR-sensitive approaches to determine if homologous recombination
mammalian cell mutants that were characterized were is perturbed in this cell line. The first approach was to
found to be defective for NHEJ, as demonstrated by evaluate pathways of integration of transfected DNA;
impaired V(D)J recombination (Fulop and Phillips, 1990; the second was to directly examine chromosomal DSB
Taccioli et al., 1993) or chromosomal NHEJ (Liang et al., repair at the locus of integration. The Brca12/2 and con-
1996). Recently, two IR-sensitive cell lines were shown trol Brca11/2 310.7 cell lines were evaluated for gene
to have homologous repair defects (Johnson et al., 1999; targeting proficiency at two loci, Rb on chromosome 14
Pierce et al., 1999). These lines are deficient in the and pim1 on chromosome 17. The pim1-Q targeting
RAD51-related proteins XRCC2 and XRCC3 (Cartwright vector (Figure 1A) contains a promoterless hygromycin
et al., 1998; Liu et al., 1998), confirming a contribution of resistance (hygR) gene cloned in frame with pim1 coding
the RAD51 pathway to homologous repair in mammalian sequences (te Riele et al., 1990). The hyg gene is ex-
cells. pressed when the vector correctly gene targets at the
The products of both hereditary breast cancer genes, pim1 locus or when a fortuitous nonhomologous integra-
tion occurs adjacent to promoter sequences. The
pim1-Q targeting vector was electroporated into both§ To whom correspondence should be addressed (e-mail: m-jasin@
ski.mskcc.org). cell lines, and hygR colonies were selected. Southern
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Figure 1. The Efficiency of Gene Targeting Is Reduced in Brca12/2 Cells
(A) Gene targeting strategy at the pim1 locus. In the pim1-Q targeting vector, the promoterless hygR gene is cloned in frame with pim1 exons
(black boxes) and has 0.5 kb of pim1 homology on the left arm and 3.7 kb of homology on the right arm (te Riele et al., 1990). Although
promoterless in the targeting vector, the hygR gene is expressed from the endogenous pim1 promoter when it has homologously integrated.
The targeting vector also contains a substrate for DSB repair that consists of two defective neo genes, Sneo and Pneo, separated by the 2.2
kb pgk-tk1 gene. Mutations in the Sneo and Pneo genes are linker insertions of I-SceI (S) and PacI (P) endonuclease recognition sites,
respectively. The Sneo gene has a polyoma/tk promoter; the Pneo gene is promoterless. H, HincII site.
(B) Southern blot analysis of hygR clones derived from transfection of Brca12/2 and Brca11/2 cell lines with the pim1-Q targeting vector. DNA
was digested with HincII and hybridized with the pim1 probe shown in (A). The wild-type and targeted pim1-Q alleles are 3.6 and 2.4 kb,
respectively.
(C) Gene targeting strategy at the Rb locus in the region of Rb exons 20 and 19 (black boxes). In the Rb-O targeting vector, the pgk-hygR
gene is inserted into exon 19 and has 7 kb of Rb homology on the left arm and 2.4 kb of homology on the right arm (te Riele et al., 1992).
The targeting vector also contains the same DSB repair substrate described in (A). E, EcoRI site.
(D) Southern blot analysis of hygR clones derived from transfection of the Brca12/2 and Brca11/2 cell lines with the Rb-O targeting vector. DNA
was digested with EcoRI and hybridized with the Rb probe shown in (C). The wild-type and targeted Rb-O alleles are 10 and 5.0 kb, respectively.
analysis demonstrated that most of the hygR Brca12/2 (Figure 1C) contains an intact hygR gene expressed from
a pgk promoter. As at the pim1 locus, most of the hygRclones were derived from random integration of the
Brca12/2 clones were derived from random integrationpim1-Q targeting vector (Figure 1B), with only 3% of
of the targeting vector (Figure 1D), with less than 1% ofclones derived from gene targeting (Table 1). By con-
clones derived from gene targeting at the Rb locus (Ta-trast, efficient gene targeting was observed in the
ble 1). Conversely, the Brca11/2 cell line efficiently inte-Brca11/2 cell line (Figure 1B) with 70% of the clones
grated the Rb-O targeting vector at the Rb locus (Figurecorrectly targeted (Table 1), similar to what has pre-
1D), with 48% of the clones correctly targeted (Table 1).viously been observed with this targeting design (te
This is within the range of what has previously beenRiele et al., 1990).
observed for this locus (te Riele et al., 1992; de Wind etTo confirm that this 23-fold decrease in gene targeting
al., 1995). Thus, the Brca12/2 cells had a 53-fold decreaseefficiency in the Brca12/2 cell line was not related to
in gene targeting efficiency as compared with thethe promoterless targeting vector design or locus of
Brca11/2 cell line (Table 1).integration, gene targeting was also examined at Rb, a
Since the efficiency of gene targeting is expressed asstandard test locus for recombination (te Riele et al.,
the ratio of the number of gene targeted to total hygR1992; de Wind et al., 1995). The Rb-O targeting vector
clones analyzed, two parameters may be affected, the
frequency of gene targeting and/or the frequency of
random integration. We observed that the total number
Table 1. Gene Targeting Efficiency of Brca11/2 and Brca12/2
of hygR clones in the Brca12/2 cells was increased asCells at Two Genomic Loci
compared to the Brca11/2 control cells following trans-
Targeting Construct fection with the linear Rb-O targeting construct (2-fold)
or with a circular hygR control plasmid (5-fold). With theCell Line pim1-Q Rb-O
Rb-O targeting construct, therefore, the 53-fold differ-
Brca11/2 70% (50/71) 48% (90/192)
ence in targeting efficiency can be attributed to a 13-Brca12/2 3% (2/68) 0.9% (4/460)
fold decrease in gene targeting and a 4-fold increase in
The efficiency is expressed as the percentage of clones with a random integration. Thus, both parameters were af-
homologous integration relative to the total number of clones ana- fected, although a greater effect was seen on the fre-
lyzed. Absolute numbers are given in parentheses.
quency of gene targeting.
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Table 2. Frequency of Thymidine Kinase Loss in pim1-Q Cell
Lines as Measured by Resistance to the Nucleotide Analog
FIAU
Frequency of FIAUR Colonies
Cell Line Spontaneous DSB-Induced
Brca11/2
310.7.Q4 2.4 3 1024 6.9 3 1023
310.7.QA4 2.7 3 1024 7.2 3 1023
Brca12/2
236.44.QC12 5.8 3 1025 1.4 3 1023
Figure 2. Induction of FIAUR by DSB Repair
Depiction of a portion of the pim1-Q allele highlighting DSB induction one of the Brca alleles in the Brca12/2 cells (Gowen et
at the I-SceI site in Sneo. FIAUR can be acquired through DSB repair al., 1996), G418 selection was not informative for these
by homologous recombination (HR) between the direct Sneo and cells. Deletional homologous recombination can occur
Pneo repeats or nonhomologous (NH) events such as deletions of by two mechanisms, single-strand annealing, in which
variable size (D). To distinguish these two broad classes of events,
the intervening tk gene is physically deleted, or recip-Southern blots were done on genomic DNA from individual FIAUR
rocal exchange between repeats on either the sameclones restricted with XhoI (X) and BglII (B) and probed with a 526
bp EagI/NcoI neo fragment. With this digest, HR events have a 1.8 chromatid or sister chromatid, in which the tk gene is
kb band that contains an NcoI (N) site, whereas a product of variable present on the reciprocal product. Nonhomologous
size or complete loss of neo hybridization is seen in NH events (data events would also give rise to FIAUR by tk gene deletion,
not shown). Complete loss of neo hybridization requires a deletion but these deletions would be variable, removing part or
of at least 4 kb.
all of the gene.
Brca12/2 and Brca11/2 cell lines containing the pim1-Q
or Rb-O allele were electroporated with the pCbASceTo further investigate potential factors that may con-
tribute to either a decrease in gene targeting or an in- plasmid in which I-SceI endonuclease is expressed from
a chicken b-actin promoter. Cell viability following I-SceIcrease in nonhomologous integration, DNA uptake and
cell cycle distribution of transfected cells were exam- expression did not differ between the Brca12/2 and
Brca11/2 cell lines. Cells were grown in nonselectiveined. A vector expressing a nuclear localized green fluo-
rescent protein (GFP) from a chicken b-actin promoter media for 6 days to ensure loss of residual tk protein,
followed by replating and selection in FIAU. DSBs sub-was transfected into the Brca12/2 and Brca11/2 cell lines.
Cells were analyzed for GFP expression and cell cycle stantially increased the frequency of FIAUR clones in
both the Brca12/2 and Brca11/2 cell lines containing thedistribution by flow cytometry 24 hr following electropor-
ation. Green fluorescence and cell cycle distribution, as pim1-Q allele. However, the Brca12/2 pim1-Q cell line
had an approximately 5-fold lower frequency of bothmeasured in both unfixed and ethanol-fixed cells, were
equivalent in the Brca12/2 and Brca11/2 cell lines (data spontaneous and DSB-induced FIAUR colonies as com-
pared to either of the Brca11/2 pim1-Q cell lines (Tablenot shown), indicating similar DNA uptake and cell cycle
kinetics. 2). In the Rb-O cell lines, whether Brca12/2 or Brca11/2,
spontaneous loss of tk expression was extremely high,
possibly due to occlusion or epigenetic modification ofBrca1 Controls Homology-Directed Repair
of Chromosomal DSBs the pgk promoter, with only a minimal induction of tk
loss by I-SceI expression. Therefore, the Rb-O clonesWe next investigated the Brca1-deficient cells for the
repair of chromosomal DSBs. In the gene targeting ex- were not examined further using the tk assay.
To identify the molecular events leading to FIAUR,periments, a direct repeat recombination substrate con-
taining the cleavage site for a rare-cutting endonuclease Southern blot analysis was performed on genomic DNA
from the individually expanded pim1-Q clones using thewas integrated at the pim1 (Figure 1A) and Rb loci (Figure
1C). The direct repeat consists of two differentially mu- neo gene as probe (data not shown). For both the
Brca12/2 and Brca11/2 pim1-Q cell lines, the major path-tated neomycin phosphotransferase (neo) genes, Sneo
and Pneo, separated by a thymidine kinase (tk) gene. way leading to FIAUR was a deletional recombination
event. This event was found in 93.2% of the Brca11/2Inserted into the Sneo gene was the 18 bp recognition
site for the I-SceI endonuclease (Figures 1A and 1C), FIAUR clones (123/132) and 93.8% of the Brca12/2 FIAUR
clones (106/113). Consistent with this, G418 selectionwhich disrupts the gene. When the I-SceI site is cleaved
in vivo, homologous recombination with the Pneo gene (neo1) of the Brca11/2 cell lines demonstrated a concor-
dance in the frequency of deletional recombinationwill repair the DSB. Alternatively, nonhomologous pro-
cesses can be used to repair the DSB. Since each pro- events as measured by combined G418 and FIAU selec-
tion or FIAU selection only. The remaining clones hadcess can give rise to multiple products, two different
assays were used to score DSB repair events. a neo band of different size from the parental clone
or complete loss of the neo hybridization signal, eachThe first assay was based on loss of the tk gene
that causes cells to become resistant to the nucleotide indicative of NHEJ involving a large deletion. Since the
major event leading to tk loss was homologous recombi-analog FIAU (Figure 2). A deletional homologous recom-
bination event would precisely remove one of the neo nation, the 5-fold lower frequency of DSB-induced FIAUR
clones indicates that there is a homologous repair defectrepeats along with the tk gene. A neo1 gene would also
be restored, but since a neo gene was used to knockout in the Brca1-deficient cells.
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Figure 3. Brca12/2 Cells Have Impaired Homologous Repair of Chromosomal DSBs
(A and B) To analyze DSB repair, Brca12/2 and Brca11/2 cell lines containing the Rb-O (A) and pim1-Q (B) alleles were electroporated with an
I-SceI expression vector. Primers pmcF and tkR were used to amplify repair products resulting from HR or NHEJ, as shown. The HR event
detected by these primers is a noncrossover gene conversion of the cleaved Sneo gene by the downstream Pneo gene. Noncrossover HR
results in an NcoI1 neo1 gene followed by tk sequences. By contrast, NHEJ of the DSB results in an NcoI2/I-SceI2 neo2 gene. The other
primer set, pmcF and hygR (Rb-O) or pmcF and pim1R (pim1-Q), was used to amplify the HR deletion product that is followed by hyg (A) or
pim (B) sequences, as shown.
(C and D) A consistent reduction in the HR product is seen in the Brca12/2 cell lines, as demonstrated by Southern blot analysis of the Rb-O
(C) and pim1-Q (D) DSB repair products. Two independently derived cell lines were analyzed for each genotype, except for the Brca12/2
pim1-Q genotype in which only one cell line was analyzed. DSB repair products were amplified by PCR using the indicated primers, digested
with NcoI, I-SceI (data not shown), or both enzymes, and analyzed by Southern blotting using the neo probe shown in Figure 2. Primers pmcF
and tkR amplify a 1.2 kb neo/tk gene fragment that is cleaved with NcoI in the HR events to produce an 0.8 kb fragment. NHEJ products are
uncleaved by both NcoI and I-SceI, maintaining the 1.2 kb fragment. The increase in hybridization signal of the 0.8 kb band in the NcoI/I-SceI
lanes as compared with the NcoI lanes is the result of amplification of a residual amount of I-SceI1 material. Amplification with primers pmcF
and hygR (C) or pmcF and pim1R (D) results in a product that is almost exclusively NcoI1, as expected.
(E–H) Quantitation of the HR and NHEJ products after DSB repair demonstrating impaired HR in the Brca12/2 cell lines. Both noncrossover
HR (primer pair pmcF and tkR, [E and G]) and HR resulting in a deletion (primer pairs pmcF and hygR, [F]; pmcF and pim1R, [H]) are reduced in
the Brca12/2 Rb-O (E and F) and pim1-Q (G and H) cell lines. The relative percentage of the noncrossover HR product (black boxes) and the
NHEJ (stacked white boxes) product obtained in each cell line indicates a 5-fold decrease in HR and 1.6-fold increase in NHEJ in the Brca12/2
cell lines as compared with the Brca11/2 control cell lines (E and G). HR resulting in a deletion product is reduced in the Brca12/2 cell lines
approximately 6-fold, as determined by quantitating the amount of the NcoI1 product and normalizing it to the amount of product obtained
in the Brca11/2 cell lines (black boxes, [F and H]). Error bars are present in all samples except the normalized Brca11/2 cell lines in (F) and
(H) and the Brca12/2 cell lines in (F), for which only one experiment was performed. In (E) and (G), the bar graphs do not end at 100%, since
a portion of the amplified product is I-SceI1.
Brca1-Deficient Cells Have Impaired Homologous to the locus after repair, such as those resulting from
homologous repair by noncrossover gene conversionRepair of DSBs but Are Proficient
at Nonhomologous Repair and from NHEJ, which usually involves small deletions
or insertions. PCR with a second set of primers wasOur previous work demonstrated that the major portion
of DSB repair events are from homologous or NHEJ used to measure the appearance of the deletional ho-
mologous recombination product. This would confirmrepair that lead to minimal changes to the locus, with
only a few percent of events resulting in gross chromo- the tk gene loss results obtained in pim1-Q cell lines
and allow detection of events in the Rb-O cell lines. Withsomal rearrangements (Liang et al., 1998). Therefore,
a second assay was employed to detect more subtle this second set of primers, the downstream primer was
specific to each locus (hygR for Rb-O, pim1R for pim1-Q;changes to the locus and to assess the relative contribu-
tions of NHEJ and homologous recombination to DSB Figures 3A and 3B).
The pim1-Q and Rb-O cell lines were transfected withrepair. PCR with primers that flank the DSB site (pmcF
and tkR; Figures 3A and 3B) detects minimal changes or without the I-SceI expression vector and grown in
Brca1 Controls Homology-Directed DNA Repair
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nonselective media. Genomic DNA was isolated either Discussion
immediately after transfection or 48 hr later and then
These results are the first to directly demonstrate thatcleaved with commercially available I-SceI endonucle-
the hereditary breast cancer gene Brca1 controls homol-ase to reduce amplification of genomic DNA that main-
ogous recombination. Cells deficient in Brca1 have bothtained an intact I-SceI site. PCR was performed with
decreased gene targeting and, significantly, impairedeach set of primers, and the products were digested with
homologous repair of a damaged chromosome. Nonho-NcoI and/or I-SceI and analyzed by Southern blotting to
mologous recombination is not reduced in these cells,identify homologous (NcoI1/I-SceI2) and NHEJ (NcoI2/
but rather is somewhat elevated, especially as measuredI-SceI2) repair events. In control transfections without
by increased random integration of transfected DNA.the I-SceI expression vector, only a small amount of
Although the mechanism of nonhomologous integrationproduct was amplified with either primer set, and it was
is not known, it is possible that as a result of the homolo-I-SceI1, demonstrating a requirement for in vivo cleav-
gous repair defect the Brca12/2 cells have an elevatedage and repair to generate I-SceI2 products (data not
level of spontaneous DSBs genome-wide into whichshown).
transfected DNA can insert.Southern blots from one transfection of the I-SceI
Brca1 disruption by targeted mutagenesis has beenexpression vector are shown in Figures 3C and 3D. With
reported by several groups to result in embryonic deaththe pmcF and tkR primer set, approximately 90% of the in mice, with embryos exhibiting severe growth retarda-
amplified product was I-SceI2 (data not shown). The
tion (Gowen et al., 1996; Hakem et al., 1996; Liu et al.,
NcoI2/I-SceI2 NHEJ product was readily detected in all
1996; Ludwig et al., 1997; Shen et al., 1998). Heterogene-
of the cell lines, with an equal or slightly higher amount ity is observed in the timing of embryonic death both
in the Brca12/2, as compared with the Brca11/2, cell lines. within a mouse line containing a particular disrupting
By contrast, a consistently lower level of the NcoI1 gene mutation and between mouse lines containing different
conversion product was detected in the Brca12/2 cell mutations. Most Brca1 mutations result in lethality prior
lines (Rb-O, Figure 3C; pim1-Q, Figure 3D). The second to embryonic day 9 (Hakem et al., 1996; Liu et al., 1996;
set of primers, pmcF and either hygR or pim1R, gave a Ludwig et al., 1997; Shen et al., 1998), whereas the Brca1
predominantly NcoI1 product ($97%), as expected. As mutation present in our ES cell line allows mice to survive
with the gene conversion product, this deletional recom- to embryonic day 9 or 10 (Gowen et al., 1996). (In rare
bination product was consistently lower in the Brca12/2 instances, when combined with p53 mutation, live births
cell lines at both the Rb-O and pim1-Q loci as compared are obtained [Cressman et al., 1999b].) The mutant
with the Brca11/2 cell lines. Brca1 gene is disrupted by replacement of the terminal
Since G418 selection was informative in the Brca11/2 portion on intron 10 and the beginning of exon 11 with
cells, the relative contribution of the two recombination a selectable marker gene, resulting in loss of the full-
products could be assessed. Southern blot analysis of length Brca1 transcript (Gowen et al., 1996). The muta-
neo1 clones demonstrated that gene conversions and tion does not result in a complete null allele, since an
deletional homologous recombination events occurred exon 10–12 splice variant is expressed that results in
an in-frame fusion between the two exons (Cressmanat similar frequencies (approximately 40% and 60%,
et al., 1999a; L. C. Gowen and B. H. K., unpublishedrespectively; data not shown). The similar frequency of
data). Prolonged survival of mouse embryos containingthe two products, rather than a predominance of the
an exon 10–12 splice variant generated by lox–cre re-deletion product (Liang et al., 1998), suggests that a
combination has also been reported (Xu et al., 1999).major pathway leading to the deletional homologous
Exon 11 of Brca1 encodes approximately 60% of theproduct is a conservative recombination pathway (Szos-
protein (Bennett et al., 1995; Lane et al., 1995), includingtak et al., 1983), rather than single-strand annealing.
the RAD51 interacting domain as mapped in the humanControl experiments using cell lines containing either
protein (Scully et al., 1997). Consistent with this, ourSneo or Pneo alone (Moynahan and Jasin, 1997) demon-
Brca12/2 ES cell line is partially defective in Rad51 focusstrated the dependence on having two homologous neo
formation following DNA damage with the cross-linkinggenes for the high frequency of restoration of an intact
agent cisplatin (D. K. Bishop, personal communica-neo gene. Upon I-SceI expression, neo1 colonies were
tion). We expect that the homologous repair defect wenot obtained in cell lines containing Pneo alone and
observed in this mutant would be further magnified bywere obtained at a frequency more than two orders of
complete loss of Brca1 protein and that a more severe
magnitude lower in cell lines containing Sneo alone (4 3
repair defect could contribute to the cellular lethality
1025) as compared with the Rb-O cell lines (8 3 1023). observed in other Brca1 mutants, due to an inability to
These neo1 clones derived from the Sneo cells arose repair spontaneous lesions. Alternatively, growth con-
from NHEJ (Moynahan and Jasin, 1997). trol and homologous repair may be separable, such that
To quantitate the defect in homologous recombina- cells may be viable but exhibit genomic instability and
tion due to Brca1 mutation, several experiments were a propensity to tumorigenesis. Along with a role for
performed in the pim1-Q and Rb-O cell lines. As summa- Brca1 in homologous repair in mitotically growing cells,
rized in Figures 3E–3H, the Brca12/2 cells have a consis- a role in homologous recombination during meiosis is
tently 5- to 6-fold lower level of homologous repair of supported by the block in spermatogenesis observed
the chromosomal DSB, by both noncrossover gene con- in the rare animals that have survived to adulthood with
version and deletion. No gross defect in NHEJ was ob- this mutation (Cressman et al., 1999b).
served in the Brca12/2 cells, as NHEJ was increased by In addition to the homologous repair defect reported
1.5- to 1.6-fold in the Brca12/2 cells as compared to the here, Brca1 has been implicated in transcription-cou-
pled repair (TCR) of oxidative DNA damage (Gowen etBrca11/2 cells.
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al., 1998; Abbott et al., 1999; Cressman et al., 1999b). stability in the absence of exogenous damage. Thus,
Other mammalian repair genes have been implicated when homologous repair is defective, nonhomologous
in TCR of oxidative damage, including CSA and CSB processes may promote aberrant types of repair.
(Leadon and Cooper, 1993), which are also involved in In summary, the homologous repair defect demon-
TCR of UV damage (Bootsma et al., 1998). Mutations in strated here supports the hypothesis of a caretaker role
these genes lead to Cockayne syndrome, which is not for the BRCA1 hereditary breast cancer gene (Kinzler
characterized by cancer predisposition, suggesting that and Vogelstein, 1997), whereby mutation of the gene
a defect in TCR of oxidative damage is not sufficient leads to a highly penetrant predisposition to early breast
to promote tumorigenesis. Mutation of another gene, and ovarian cancer.
MSH2, which is involved in mismatch repair, also leads
to impaired TCR of oxidative damage (Leadon and Experimental Procedures
Avrutskaya, 1997). In this case, the mutation predis-
DNA Manipulationsposes individuals to colorectal cancer due to mismatch
The pim1-Q targeting vector was constructed by modifying the pre-repair deficiency (Boland, 1998). One possibility is that
viously described gene targeting vector, p59 (te Riele et al., 1990),poor repair of oxidative DNA damage results in a general
to contain the Sneo and Pneo genes (Moynahan and Jasin, 1997).
inhibition of transcription, which thereby abrogates An EcoRI/BamHI fragment containing a promoterless Pneo gene
strand-specific repair. was cloned adjacent, but in opposite orientation, to the HSV-tk gene
The importance of homologous recombination as a that is driven by a pgk promoter. A XhoI/HindIII fragment containing
the entire Sneo gene was inserted downstream of pgk-tk, creatingDNA repair pathway is well established in yeast, whereas
the DSB repair substrate Sneo-tk1-Pneo. This repair substrate wasits role in mammalian cells is just emerging. A significant
inserted at a unique NotI site downstream of the p59 hyg codingfraction of DSB-promoted recombination events be-
sequence to create pim1-Q. The Rb-O targeting vector was con-tween direct repeats in mammalian chromosomes have structed by modifying the previously described “M” gene targeting
recently been demonstrated to involve sister chromatids vector (Moynahan and Jasin, 1997). Sneo-tk1-Pneo and a BglII pgk-
(Johnson et al., 1999). Thus, we expect that the homolo- hyg fragment (te Riele et al., 1992) were inserted into the BglII/
EcoRV sites of the Rb M allele, deleting exon 19 and a portion ofgous repair defect observed in the Brca12/2 cells may
intron 19.reflect, at least in part, decreased repair from the sister
The forward primer, pmcF (59-GAGCAGTGTGGTTTTGCAAG-39) waschromatid. High levels of BRCA1 are found in proliferat-
865 bp upstream of the I-SceI site. The reverse primers tkR (59-GGAing cells in S phase (Chen et al., 1996; Vaughn et al.,
ATGGTTTATGGTTCGTGG-39), hygR (59-TACTCGCCGATAGTGGAA1996), as would be predicted for a protein involved in ACC-39), and pim1R (59-TTCCAGGCCGGCACCTTG-39) were 352 bp,
sister chromatid repair. Although repair substrates nec- 3.4 kb, and 3.4 kb downstream from the I-SceI site, respectively.
essarily measure homologous recombination between After deletional homologous recombination, the hygR and pim1R
primers hybridized 342 and 322 bp, respectively, downstream ofunequally positioned sequences on sister chromatids,
the NcoI site in the neo1 gene. Quantitation of PCR products wasrepair of DSBs or other types of DNA damage from an
performed with Phosphoimager analysis and ImageQuant software.equivalently positioned sequence on the sister chroma-
tid would be predicted to be as or more frequent and
Cell Transfectionswould precisely restore the sequence that was present
Brca12/2 and Brca11/2 ES cell lines have previously been described
before the chromosome was damaged. (Gowen et al., 1996). The two Brca1 alleles used to construct the
An impaired ability to precisely repair DSBs from the Brca12/2 cell line were disrupted by hprt and neo selectable markers.
sister chromatid would be predicted to result in genetic The Brca12 allele in the Brca11/2 cell line is disrupted by hprt. ES
cells were electroporated with 75 mg of the linear pim1-Q or Rb-Oinstability in mammalian cells. Consistent with a role
targeting fragments and then selected in hygromycin (110 mg/ml forfor Brca1 in maintaining genetic stability are the recent
pim1-Q; 200 mg/ml for Rb-O). For FIAUR experiments, ES cells wereobservations of chromosomal aberrations in Brca1-defi-
electroporated at 250 V/960 mF with 100 mg of pCbASce (Richardson
cient mouse (Xu et al., 1999) and BRCA1-deficient hu- et al., 1998) or mock DNA and plated in nonselective media at 1 3
man cells (Tirkkonen et al., 1997; Tomlinson et al., 1998). 104 cells/plate. After 6 days, cells were replated in media containing
A dramatic increase in gross chromosomal aberrations 0.6 mM FIAU at a density of 5 3 104 cells/plate (experiments 1 and
is a hallmark of the chromosome instability disorders 2) or 1.0 mM FIAU at a density of 1 3 105 cells/plate (experiment
3). FIAUR clones were picked and expanded in 96-well plates forincluding Bloom syndrome, Werner syndrome, Nijmegen
Southern analysis or stained and counted for derivation of spontane-breakage syndrome, and ataxia-telangiectasia (Meyn,
ous and DSB-induced repair frequencies. Conditions were altered1997). Although the function of the genes defective in
in experiment 3 to allow for molecular analysis of a larger number
each of these syndromes has not been conclusively of FIAUR clones.
determined, they each appear to be involved in DNA
damage recognition and/or repair. Two mammalian cell Acknowledgments
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